FLGT
Fulgent Genetics Inc
NASDAQ · Health Care
$23.44
-0.27 (-1.14%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 289.82M | 440.12M | 264.74M | 242.23M | 275.80M |
| Net Income | -43,663,749 | -59,677,105 | 39.74M | 32.57M | 36.27M |
| EPS | — | — | — | — | — |
| Profit Margin | -15.1% | -14.3% | 15.0% | 13.5% | 13.2% |
| Rev Growth | -34.2% | -34.2% | +4.4% | -1.5% | -4.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 1.16M | 1.16M | 219.50M | 257.54M | 237.86M |
| Total Equity | 361.14M | 361.14M | 520.74M | 521.51M | 552.15M |
| D/E Ratio | 0.00 | 0.00 | 0.42 | 0.49 | 0.43 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -77,154,231 | -111,308,305 | 72.57M | 59.74M | 74.06M |
| Free Cash Flow | — | — | 40.15M | 22.63M | 30.51M |